Literature DB >> 28869069

Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.

Silke Gillessen1, Johann S de Bono2, Oliver Sartor3, Aurelius Gabriel Omlin4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28869069     DOI： 10.1016/j.eururo.2017.08.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  [Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].

Authors:  M Schostak; F König; M Bögemann; P Goebell; P Hammerer; S Machtens; C Schwentner; C Thomas; G von Amsberg; F-C von Rundstedt; A Heidenreich
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

2.  PSMA diagnostics and treatments of prostate cancer become mature.

Authors:  Finn Edler von Eyben; Glenn Stewart Baumann; Richard Paul Baum
Journal:  Clin Transl Imaging       Date:  2018-03-07

Review 3.  Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.

Authors:  Finn Edler von Eyben; Giandomenico Roviello; Timo Kiljunen; Christian Uprimny; Irene Virgolini; Kalevi Kairemo; Timo Joensuu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-16       Impact factor: 9.236

4.  Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

Authors:  Simon Linder; Henk G van der Poel; Andries M Bergman; Wilbert Zwart; Stefan Prekovic
Journal:  Endocr Relat Cancer       Date:  2018-10-31       Impact factor: 5.678
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.